Business
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2026
SALT LAKE CITY, UT / ACCESS Newswire / April 23, 2026 / In the first calendar quarter (1Q) of 2026, Utah Medical Products, Inc. (Nasdaq:UTMD) attained
About this update from Utah Medical Products, Inc.
[{"type":"text","content":"SALT LAKE CITY, UT / ACCESS Newswire / April 23, 2026 / In the first calendar quarter (1Q) of 2026, Utah Medical Products, Inc. (Nasdaq:UTMD) attained financial results which were consistent with its previously announced projections for calendar year 2026. But because of the relatively short span of time, results for any given three-month period in comparison with a previous three-month period may not be indicative of comparative results for the year as a whole.Summary of results.The following is a summary comparison of 1Q 2026 with 1Q 2025 income statement measures:Revenues (Sales): (10.2%) Gross Profit (GP): ( 4.6%) Operating Income (OI): (18.7%) Net Income (NI): (14.4%) Earnings Per Share (EPS): (11.0%) Profit margins in 1Q 2026 compared to 1Q 2025 follow: 1Q 2025 1Q 2024 1Q 2026(JAN - MAR) 1Q 2025JAN - MAR Gross Profit Margin (gross profits/ sales): 60.6% 57.0%Operating Income Margin (operating income/ sales): 29.4% 32.5%EBT Margin (profits before income taxes/ sales): 36.5% 39.7%Net Income Margin (profit after taxes/ sales): 29.9% 31.3% Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros. Currency amounts throughout this report are in thousands, except per share amounts and where noted.Consolidated sales in 1Q 2026 were $987 lower than in 1Q 2025. As expected and previously reported, UTMD did not have any 1Q 2026 sales to its previous largest medical device distributor of blood pressure monitoring kits in China, or to its previous OEM customer, PendoTECH. The combined sales to those two entities in 1Q 2025 were $857, representing 87% of the lower 1Q 2026 sales. Although overall domestic sales were about the same in both 1Q 2026 and 2025, sales outside the U.S. (OUS) excluding the China distributor were another $176 lower, due to lower Filshie Clip System sales OUS.Using the same foreign currency exchange (FX) rates for sales not invoiced in USD, i.e. in \"constant currency\" terms, OUS sales would have been an additional $169 lower because of a weaker USD. FX rates for income statement purposes are transaction-weighted averages.The average FX rates from the applicable foreign currency to USD during 1Q 2026 and 1Q 2025 follow: 1Q 2026 1Q 2025 Change GBP 1.348 1.261 +6.9%EUR 1.165 1.073 +8.5%AUD 0.698 0.628...